Glycemic Control And Birth Weight With Glycated Albumin In Women With Gestational Diabetes Mellitus at Zagazig University Hospital

Background:The current monitoring standards for diabetes involve a combination of a self‐monitored blood glucose (SMBG) procedure, continuous glucose monitoring, and glycated hemoglobin A1c (HbA1c) measurement. Increasing attention has been focused on the use of glycated albumin (GA) as a parameter of the short‐term glycemic status. W aimed to evaluate GA as a potential glycemic marker in managing of gestational diabetes mellitus, and evaluating the association between glycemic control and birth weight with glycated albumin in women with GDM. Methods:Prospective study was carried out at Zagazig University Hospitals, Thirty women was control group and Thirty as the GDM (study) group. Maternal serum GA level was measured. Results:The result of this study showed that GA (24_28 weeks) more than 14.15 had sensitivity of 83.7% and specificity of 88% for prediction of fetal complication and GA (36_38 weeks) more than 14.45 had sensitivity of 85% and specificity of 88% for prediction of fetal complication.Conclusion:Strong support for the use of GA measurements, as a complement to finger stick glucose, for assessing short‐term glycemic control and predicting large birth weight in the GDM women.